These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32612152)

  • 21. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
    Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
    Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report.
    Li J; Long X; Fang X; Zhang Q; Hu S; Lin Z; Xiong N
    Clin Microbiol Infect; 2020 Aug; 26(8):1115-1117. PubMed ID: 32360448
    [No Abstract]   [Full Text] [Related]  

  • 24. Not just antibodies: B cells and T cells mediate immunity to COVID-19.
    Cox RJ; Brokstad KA
    Nat Rev Immunol; 2020 Oct; 20(10):581-582. PubMed ID: 32839569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term infection of SARS-CoV-2 changed the body's immune status.
    Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
    Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.
    Market M; Angka L; Martel AB; Bastin D; Olanubi O; Tennakoon G; Boucher DM; Ng J; Ardolino M; Auer RC
    Front Immunol; 2020; 11():1512. PubMed ID: 32655581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical lymphocyte morphology in SARS-CoV-2 infection.
    El Jamal SM; Salib C; Stock A; Uriarte-Haparnas NI; Glicksberg BS; Teruya-Feldstein J; Dembitzer FR; Nadkarni GN; Firpo-Betancourt A
    Pathol Res Pract; 2020 Sep; 216(9):153063. PubMed ID: 32825937
    [No Abstract]   [Full Text] [Related]  

  • 28. Perforin and resistance to SARS coronavirus 2.
    Cunningham L; Simmonds P; Kimber I; Basketter DA; McFadden JP
    J Allergy Clin Immunol; 2020 Jul; 146(1):52-53. PubMed ID: 32422144
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular immune responses to covid-19.
    Sewell HF; Agius RM; Stewart M; Kendrick D
    BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
    [No Abstract]   [Full Text] [Related]  

  • 30. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
    Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A
    Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Not Available].
    Balavoine JF
    Rev Med Suisse; 2020 May; 16(695):1126. PubMed ID: 32462848
    [No Abstract]   [Full Text] [Related]  

  • 32. [Not Available].
    Meylan P
    Rev Med Suisse; 2020 Nov; 16(714):2190-2191. PubMed ID: 33174706
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
    Ghosh N; Tirpack A; Chan KK; Bass AR
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33067320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
    Zhang F; Gan R; Zhen Z; Hu X; Li X; Zhou F; Liu Y; Chen C; Xie S; Zhang B; Wu X; Huang Z
    Signal Transduct Target Ther; 2020 Aug; 5(1):156. PubMed ID: 32796814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus.
    McCarty MF; DiNicolantonio JJ
    Prog Cardiovasc Dis; 2020; 63(3):383-385. PubMed ID: 32061635
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential alteration of COVID-19 by beta-mercaptoethanol.
    Click RE
    Future Microbiol; 2020 Sep; 15():1313-1318. PubMed ID: 32951474
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID-19 pneumonia: CD8
    Jiang Y; Wei X; Guan J; Qin S; Wang Z; Lu H; Qian J; Wu L; Chen Y; Chen Y; Lin X
    Clin Immunol; 2020 Sep; 218():108516. PubMed ID: 32574709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19: Small-Molecule Clinical Trials Landscape.
    Ferreira LLG; Andricopulo AD
    Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
    [No Abstract]   [Full Text] [Related]  

  • 39. SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad.
    Amor S; Baker D; Khoury SJ; Schmierer K; Giovanonni G
    Ann Neurol; 2020 Jun; 87(6):794-797. PubMed ID: 32383812
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
    Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
    Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.